CAS number：2230821-27-7 molecular formula：C47H57ClFN7O8S
Product Introduction Gefitinib-based PROTAC 3 which conjugates an EGFR binding element to a VHL ligand via a linker induces degradation of EGFR and mutants with DC50 of 11.7 nM and 22.3 nM in HCC827(Exon 19 del) and H3255 (L858R) cells, respectively.
| Chinese alias | 基于吉非替尼的PROTAC 3 | (2S,4R)-1-((S)-2-(3-(2-((5-((4-((3-氯-4-氟苯基)氨基)-7-甲氧基喹唑啉-6-基)氧)戊基)氧)乙氧基)丙酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-羧酰胺 | ||
| English alias | Gefitinib-based Proteolysis-targeting Chimera 3 | Iressa-based PROTAC 3 | (2S,4R)-1-((S)-2-(3-(2-((5-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)pentyl)oxy)ethoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-y | ||
| CAS number | 2230821-27-7 | molecular formula | C47H57ClFN7O8S |
| molecular weight | 934.52 g/mol | Exact mass | - |
| PSA | 215.000 Ų | logp | 6.900 |
No numbering system information yet
No physical and chemical property information yet
No production method and use information yet
No upstream information yet
No downstream information yet
